Carole Ho - Aug 13, 2024 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Aug 13, 2024
Transactions value $
-$53,494
Form type
4
Date filed
8/15/2024, 04:09 PM
Previous filing
Jun 7, 2024
Next filing
Aug 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$53.5K -2.34K -1.63% $22.89 141K Aug 13, 2024 Direct F1, F2
holding DNLI Common Stock 183K Aug 13, 2024 See footnote F3
holding DNLI Common Stock 25K Aug 13, 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.
F2 Includes 123,810 RSUs.
F3 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F4 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.